Search the Newsreel

IRIDEX Corp (IRIX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for IRIDEX Corp (IRIX) based on its business segments and geographic regions. The company's revenue is primarily derived from its Retina and G6 segments, with a significant portion of its sales coming from the United States and …

IRIX|IRIDEX Corp|Price:0.862|Chg%:-0.019

This article provides a comprehensive stock analysis of IRIDEX Corp (IRIX) by TradingKey, assigning it a score of 6.30/10. Key insights highlight healthy fundamentals, significant growth potential, a fairly valued stock with high institutional ownership, and a "Buy" rating from one analyst with a …

IRIDEX Corp (IRIX) Cash Flow

This article provides a detailed quarterly and annual cash flow statement for IRIDEX Corp (IRIX), covering operating, investing, and financing activities. It presents financial data including operating cash flows, net income, capital expenditures, and free cash flow over several fiscal quarters and years. The …

IRIDEX Corp - Detailed Introduction, Company Background, Business Scope, Financial Data, and Market Performance

This article provides a detailed overview of IRIDEX Corp (IRIX), an ophthalmic medical technology company specializing in laser-based systems for treating glaucoma and retina disorders. It includes company background, executive information, key financial data such as market cap and P/E, and a breakdown of …

IRIDEX Corp (IRIX) Income Statement

This article provides IRIDEX Corp's (IRIX) quarterly and annual income statements, detailing financial performance metrics such as total revenue, cost of revenue, operating expenses, and net income. It allows users to gain insights into the company's operational efficiency and trends across various fiscal periods. …

IRIDEX Corp (IRIX) Earnings Date & Reports & Earnings News

IRIDEX Corp (IRIX) Financial Health: Profitability & Balance Sheet Analysis

This article provides an analysis of IRIDEX Corp (IRIX)'s financial health, noting its current score of 7.17 and ranking within the Healthcare Equipment & Supplies industry. It highlights a stable financial status with average operating efficiency despite recent decreases in quarterly revenue and net …

IRIDEX Corp (IRIX) Institutional Confidence

The article provides an overview of IRIDEX Corp's institutional confidence score, which is currently 3.00, placing it 131st in the Healthcare Equipment & Supplies industry. Institutional shareholding has increased to 21.29%, a 16.49% rise quarter-over-quarter. The largest institutional shareholder is James Simons, and the …

IRIDEX Corp (IRIX) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of IRIDEX Corp's (IRIX) dividend and stock split history. It indicates that the company has distributed a total of $0.00 in dividends over the past five years and that there is no dividend data available. The content primarily focuses …

IRIDEX Corp (IRIX) Valuation: PE, PB & Fair Value Analysis

The article provides a valuation analysis for IRIDEX Corp (IRIX), stating its current valuation score is 9.12, ranking 36th in the Healthcare Equipment & Supplies industry. It highlights the company's P/E ratio of -4.81, indicating it is significantly below its recent high and above …

IRIDEX Corp (IRIX) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of IRIDEX Corp (IRIX), detailing its current price momentum score, support and resistance levels, and insights from various technical indicators and moving averages. As of July 23, 2026, IRIX trades between resistance at 1.12 and support at 0.81, …

Iridex expands EyeProGPO offering with EndoProbe handpieces

Iridex Corporation has expanded its EyeProGPO product offering to include its EndoProbe Handpieces, providing over 4,300 EyeProGPO members with access to preferred pricing. This move broadens access to their retina laser systems and delivery devices for ophthalmology practices, surgery centers, and hospitals. Despite trading …

More Than 4,300 EyeProGPO Members Gain Preferred EndoProbe Pricing

Iridex (NASDAQ: IRIX) has expanded its partnership with EyeProGPO, an ophthalmology group purchasing organization, to include its EndoProbe Handpieces. This addition provides more than 4,300 EyeProGPO members with access to preferred pricing on these single-use vitreoretinal laser delivery devices. The expanded offering aims to …

IRIDEX CORP (IRIX) CEO awarded RSUs, PSUs and stock options

IRIDEX CORP President and CEO Patrick Mercer has been granted significant equity awards, including 100,000 restricted stock units (RSUs), 100,000 performance RSUs, and stock options for 200,000 shares. These

IRIX Q1 2026 Earnings: EPS Beats Estimates by 58%, Stock Rises Nearly 3% - Guidance Accuracy Score

IRIX Stock Up 4% As Q1 Loss Narrows Y/Y on Glaucoma Product Growth

IRIDEX Corp (IRIX) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ...

IRIDEX Corporation Q1 2026 Earnings Call Summary

Iridex Reports First Quarter 2026 Financial Results

Iridex Reports Fourth Quarter and Full Year 2025 Financial Results